TradingViewTradingView

Natera Executives and Directors Conduct Stock Transactions to Satisfy Tax Obligations

Reporter NameRelationshipTypeAmountSEC Filing
Chapman Steven LeonardCEO AND PRESIDENTSell$2,269,928Form 4
Fesko JohnPRESIDENT, CHIEF BUS. OFFICERSell$668,453Form 4
Moshkevich SolomonPRESIDENT, CLINICALDIAGNOSTICSSell$862,687Form 4
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICERSell$791,693Form 4
Rabinowitz MatthewEXECUTIVE CHAIRMANSell$995,715Form 4
Sheena JonathanDirectorSell$203,612Form 4
Brophy Michael BurkesCHIEF FINANCIAL OFFICERSell$1,052,112Form 4

Several executives and directors at Natera, Inc. have recently sold shares of the company's common stock, primarily to satisfy tax obligations related to the vesting of Restricted Stock Units (RSUs). These transactions were executed under plans that comply with Rule 10b5-1(c) of the Exchange Act.

Steven Leonard Chapman, CEO and President, sold 13,685 shares at prices ranging from $165.8687 to $167.385, totaling $2,269,928. Following these sales, Chapman directly owns 253,944 shares.

John Fesko, President and Chief Business Officer, sold 4,030 shares at prices ranging from $165.8687 to $167.39, totaling $668,453. Fesko now directly owns 143,200 shares.

Solomon Moshkevich, President of Clinical Diagnostics, sold 5,201 shares at prices of $165.8687 and $167.36, for a total of $862,687. Moshkevich's direct ownership stands at 135,483 shares.

Daniel Rabinowitz, Secretary and Chief Legal Officer, sold 4,773 shares at prices of $165.8687 and $167.1998, totaling $791,693. Rabinowitz directly owns 213,020 shares post-transaction.

Matthew Rabinowitz, Executive Chairman, sold 6,003 shares at prices of $165.8687 and $167.36, totaling $995,715. He directly owns 2,383,177 shares and indirectly owns 84,000 shares through his spouse.

Sheena Jonathan, Director, sold 1,217 shares at prices ranging from $165.8687 to $176.6, totaling $203,612. Jonathan's direct and indirect ownership totals 349,504 shares.

Michael Burkes Brophy, Chief Financial Officer, sold 6,221 shares at prices ranging from $165.8687 to $176.6, totaling $1,052,112. Brophy directly owns 101,811 shares following these transactions.


Mais notícias de TradingView

Mais notícias